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Welding fumes contain metals and other toxic substances known or strongly suspected to be related with oxidative stress and
premature cellular senescence. Apolipoprotein J/Clusterin (ApoJ/CLU) is a glycoprotein that is diﬀerentially regulated in various
physiological and disease states including ageing and age-related diseases. In vitro data showed that exposure of human diploid
ﬁbroblasts to hexavalent chromium (Cr(VI)) resulted in premature senescence and signiﬁcant upregulation of the ApoJ/CLU pro-
tein. In this study we analyzed blood and urine samples from shipyard industry welders being exposed to diﬀerent levels of Cr(VI)
over a period of ﬁve months in order to assay in vivo the relation of ApoJ/CLU serum levels with Cr(VI). Our ﬁndings conﬁrmed
the previously reported in vitro data since reduction of Cr levels, after a worksite intervention, associated with lower levels of
ApoJ/CLU serum levels. We concluded that the human ApoJ/CLU gene is responsive to the acute in vivo oxidative stress induced
by heavy metals such as hexavalent chromium.
Copyright © 2008 Evangelos C. Alexopoulos et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
Welders are exposed to many air contaminants such as iron
oxide, manganese, nickel, cadmium oxide, zinc oxide, chro-
mium, ﬂuoride, ozone, nitrogen oxides, carbon monoxide,
and others [1]. Previous studies suggested that the increased
generation of highly reactive oxygen species, which result
in oxidative tissue damage, is responsible for the toxicity of
Cr(VI), Fe, Ni, and other metals [2–6]. Welding processes,
like manual metal ﬁnishing, are commonly used in stainless
steel welding and produce mainly chromium, nickel, man-
ganese, ﬂuorides, nitrogen oxide, and ozone [1].
The genotoxic, mutagenic, and cytotoxic eﬀects of hex-
avalent chromium (Cr(VI)) exposure are well documented
[2–6]. Chromium is absorbed via the gastrointestinal and
respiratory tracts and the skin. Even though chromium kine-
tics is not fully clear, key features mainly include diﬀerential
absorption of Cr(VI) and Cr(III), rapid reduction of Cr(VI)
to Cr(III) in all body ﬂuids and tissues, modest incorpo-
ration of chromium into bone, and concentration- depen-
dent urinary clearance [7]. Compared to the Cr(III) ions
that cross the membranes slowly by simple diﬀusion, Cr(VI)
readily crosses cell membranes in the form of tetrahedral
chromate anions through the general anion transport sys-
tem and for that reason intracellular Cr is considered as in-
dicative of Cr(VI) exposure [8–10]. Inside the cell, Cr(VI)
is reduced to Cr(III), generating intermediate Cr(V) and
Cr(IV) ions, oxygen, and organic radicals. The existing evi-
dence points to Cr(V) as the main reactive species in Cr(VI)-
induced genotoxicity [11, 12] through direct redox reac-
tions with DNA, formation of DNA adducts, and Zn(II)
thiolate complexes [13] which, in addition to Cr(VI) com-
plexes formed mainly with cellular thiols, are likely triggers
of a chain of events leading to carcinogenesis [14]. Prod-
ucts including DNA strand breaks, Cr-DNA adducts, and2 Bioinorganic Chemistry and Applications
DNA-protein cross-links have been shown to occur in vivo
and in vitro [15, 16].
The distribution of chromium to diﬀerent compart-
ments, the possibility of diﬀerent transport mechanisms
and pathways combined with the potential for reduction of
Cr(VI), complicates further the kinetic models as far as it
concerns excretion [17, 18]. The decrease of Cr(VI) levels
from body ﬂuids seem to follow a biphasic blood clearance
and a bi/multiphasic urinary excretion pattern, which sug-
gest the existence of several slow-releasing storage compart-
ments. Several studies have shown half-times ranging be-
tween a few days (2–6) up to more than 3 months or even
two years for the fast/medium and slow phase elimination,
respectively [19–21].
Recently reported data suggested that exposure of hu-
man diploid ﬁbroblasts to hexavalent chromium Cr(VI) at
concentrations equal or 10 fold lower than the maximum
permissive values (MPV) resulted in cell death or prema-
ture cellular senescence, respectively [22]. The cellular senes-
cence phenotype was accompanied by elevated protein levels
of apolipoprotein J/clusterin (ApoJ/CLU) [22].
Human ApoJ/CLU is a heterodimeric secreted glycopro-
tein that was initially puriﬁed from serum and identiﬁed as
an apolipoprotein [23]. Not only ApoJ/CLU functions as an
apolipoprotein, but it is also implicated in additional intra-
or extracellular processes. For instance, it has been proposed
that the secreted ApoJ/CLU protein functions as an extracel-
lular chaperone [24]. CLU is diﬀerentially regulated in many
severe physiological disturbance states including ageing, sev-
eral neurological diseases, and in vivo cancer progression
[23].
Interestingly and surprisingly, in a cross-sectional ﬁeld
survey, it has been also found that welders and sandblasters
(known to be exposed to high levels of heavy metals and
other chemicals) exhibited lower ApoJ/CLU serum levels
as compared to other low chemically exposed occupational
groups like white collars and electricians [22]. Given these
observations in this study we analyzed blood and urine sam-
ples from shipyard industry welders being exposed to diﬀer-
ent levels of Cr(VI) over a period of ﬁve months in order
to assay in vivo the relation of ApoJ/CLU serum levels with
Cr(VI).
2. MATERIALS AND METHODS
2.1. Samplecollection
Blood and urine samples were collected from male welders
(n = 75) and sandblasters (n = 5) of a shipyard industry ac-
cording to standard procedures. Subjects aged between 22 to
58 years old (mean 40.14) had worked for 2 to 35 years in the
shipyard (mean 18.5) and agreed to participate in this study
after signing an informed consent. The male welders exam-
ined in this study were selected among welders who welded
on both MS and SS. Welding has taken place inside work-
shops or SS tanks. Welders used electrodes containing var-
ious metals in diﬀerent concentrations like Mn (0.8–6.5%),
Ni (0.02–8.8%), Cr (0.03–22.5 % ) ,M o ,S i ,F e ,Z n ,C u ,a n d
other substances. All welders had access to local suction at
their workplace and used it more than 75% of the weld-
ing time. None wore airstream helmet, but all occasionally
wore ﬁlter mask for personal respiratory protection and con-
sistently used protective clothing and gloves. Each partici-
pant completed a comprehensive questionnaire on individ-
ual welding history and on welding methods and intensity
applied during the previous two weeks, month, and the pre-
vious year. They were also asked about their welding em-
ployment histories and the duration of SS welding in their
careers. As determined after detailed medical examination,
none of the subjects suﬀered any serious chronic disease.
All welders with Cr blood levels above 2μg/L( n = 9)
were selected to enter an intervention phase. This worksite
interventionaimedtolowerCr(VI)exposurethroughamin-
imization of stainless steel welding. Five months later, sam-
ple collection was repeated in this selected group of workers.
The ﬁve months period was selected based on half time of
chromium life and life cycle of erythrocytes.
In parallel to blood and urine collection, a number of
additional parameters were recorded such as age, anthropo-
metrical characteristics, smoking status, duration of employ-
ment, medical history, and detailed occupational history.
MeasurementofCrandApoJ/CLUlevelsin
bloodandurinesamples
Cr levels in blood and urine samples were measured by using
a Perkin-Elmer 600 atomic absorption spectrometer. Sam-
ples were appropriately diluted (1/2 for urine and 1/5f o r
blood) with Triton X-100 in a nitric acid solution. They were
thenanalyzedbythestandardadditioncalibrationprocedure
usinggraphitefurnace[25]atadetectionlimitof0.1μg/L.to
correctthediﬀerencesinﬂuidintake,theurinaryvalueswere
also related to the respective creatinine values. Quantitative
measurement of ApoJ/CLU serum levels by ELISA was per-
formed as described previously [22]. Additional biological
parameters assayed included γ-glutamyltranspeptidase (γ-
GT; an indicator of liver function), alanine aminotransferase
(ALT), aspartate aminotransferase (AST), total cholesterol,
triglycerides, high-density lipoprotein (HDL), low-density
lipoprotein (LDL), urea nitrogen, uric acid, fasting glucose,
erythrocyte sedimentation rate at one hour, white blood cell
count and type, platelet count, and hemoglobin. Prostate
speciﬁc antigen (PSA) level was determined in subjects aged
above 45 years old. The biochemical parameters were mea-
sured by using a Hitachi 917 analyzer and the hematological
parameters at an autoanalyzer Pedra 120.
2.2. Statisticalanalysis
Results were expressed as mean (SD) or geometric mean
(minimum-maximum). Diﬀerences between groups were
examined by Student’s t-test or Mann-Whitney U-test de-
pending on the normality of the distribution. Pearson cor-
relation analysis was used to determine possible correlations
between variables. A log transformation was used for labora-
tory variables not ﬁtting to a normal distribution. Wilcoxon
signed rank test was employed to assess the diﬀerence on
paired observations in intervention group. For comparisons,Evangelos C. Alexopoulos et al. 3
the two-tailed test was used with a type I error of α = 0.05.
Data analyses were conducted by means of the SPSS for Win-
dows 14.1.0 statistical package.
3. RESULTS
One out of three welders had a normal body mass in-
dex (BMI) (20–25kg/m2), while 18.2% were obese (BMI >
30kg/m2). Only 19.1% of the subjects were nonsmokers
and statistical analysis revealed a signiﬁcant positive correla-
tion between cigarette smoking and elevated triglyceride and
hematocrit levels. Body mass index (BMI) besides age was
also positively correlated to triglyceride level, uric acid, and
γ-GT(Table 1).Weldershadbeenwelding for11–25 daysthe
previous month and for 180–240 days the previous year.
Cr blood levels in the ﬁrst sampling ranged between 0.1–
6.1μg/L (mean 0.91; geometric mean 0.64) and urine Cr
levels ranged between 0.1–50.2μg/L (mean 1.33; geometric
mean, 0.43) or 0.03–27.27μg/g creatinine (mean 0.87; geo-
metric mean 0,25). In Table 1, relative data of subgroups are
presented. ApoJ/CLU serum concentration ranged between
653 and 3075 (mean 1168; geometric mean 1129) (OD492).
None of the hematological parameters, biochemical indica-
tors, age, BMI, or smoking status showed any statistical sig-
niﬁcantrelationwithApoJ/CLUlevels.UrineCrlevelsexhib-
itedaweakassociationwithApoJ/CLU levels(r = 0.160, P =
.157) raised when only SS welders were included in the anal-
ysis but it remained insigniﬁcant (r = 0.245, P = .097). Cor-
relation of urine Cr corrected for creatinine and ApoJ/CLU
levels was also not signiﬁcant (r = 0.185, P = .101) but also
raised in SS welders (r = 0.217, P = .143). Having observed
thattrend,weanalyzeddatafromtheﬁrstsampling concern-
ing measurements of those welders known (from their de-
tailed occupational history) to be involved recently (less than
10 weeks) in stainless steel welding. Indeed, when only this
group (n = 17) was included in the analysis, the correlation
coeﬃcient (r) of ApoJ/CLU with urine Cr rose from 0.160 to
0.333 (P = .192) and with urine Cr corrected for creatinine
rose from 0.245 to 0.453 (P = .068) but did not reach statis-
tical signiﬁcance (P = .206).
Aswedescribedpreviously,weimplementedaninterven-
tion to lower Cr(VI) blood levels in order to study the regu-
lation of ApoJ/CLU levels in human serum. All welders (n
= 9) with blood Cr levels higher than 2μg/L were assigned
to two intervention groups with diﬀerent grade of intensity,
followedaﬁve-monthinterventionprogramwhichconsisted
of a signiﬁcant diﬀerentiation (lowering) in the volume and
amount of stainless steel-mediated welding. After this pe-
riod, we recollected blood and urine and assayed the Cr and
ApoJ/CLU serum levels. In both groups, we found a signif-
icant reduction in the Cr levels in all but one blood sam-
ple (Table 2). Urine levels exhibited various trends partly ex-
plained by the intensity of intervention, in addition to evi-
dence that urine Cr reﬂects more recent exposure and it has
greater variability [26].
Interestingly, we found that the reduction of Cr levels in
bloodduetothisinterventionwasrelatedtolowerApoJ/CLU
serum levels (0.77, P = .009) (Figure 1). Higher intensity of
intervention (lower exposure to hexavalent chromium) was
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Figure 1: Relation of ApoJ/CLU levels and the reduction of
chromium blood levels (micrograms/L) (lines represent 95% mean
prediction interval).
also related to lower ApoJ levels in a statistical signiﬁcant
level (1042 versus 1362, P = .032).
The results of multivariate analysis modeling ApoJ/CLU
levels have shown that blood Cr is the main determinant of
ApoJ/CLU levels. Urine Cr holds a mild signiﬁcant inverse
association (negative β) reﬂecting perhaps diﬀerences in the
kinetics between compartments (Table 3).
4. DISCUSSION
The unifying factor in determining toxicity and carcino-
genicity for most, if not all, heavy metals including iron,
copper, chromium, vanadium, cobalt, mercury, cadmium,
and nickel is the generation of reactive oxygen and nitro-
gen species [27]. Metal-mediated formation of free radicals
causes various modiﬁcations to DNA bases, enhanced lipid
peroxidation and altered calcium and sulfhydryl homeosta-
sis. Lipid peroxides, formed by the attack of radicals on
polyunsaturated fatty acid residues of phospholipids, can
further react with redox metals ﬁnally producing mutagenic
and carcinogenic substances [27].
We have previously shown that welders and sandblasters,
who are exposed to high levels of heavy metals, exhibited
lower ApoJ/CLU serum levels as compared to other occupa-
tional groups [22]. This ﬁnding was unanticipated since ex-
posure of normal human diploid ﬁbroblasts to low noncyto-
toxic levels of Cr(VI) induced premature cellular senescence
and resulted in the upregulation of the ApoJ/CLU protein
[22]. ApoJ/CLU has a nearly ubiquitous expression pattern
in human tissues and has been implicated in various phys-
iological processes and in many severe physiological distur-
bance states including ageing, cancer progression, vascular
damage, diabetes, kidney, and neuron degeneration [28]. Al-
thoughunrelatedintheiretiologyandclinicalmanifestation,4 Bioinorganic Chemistry and Applications
Table 1: Individual characteristics and laboratory results in shipyard workers.
SS welders Sandblasters Welders
n = 47 n = 5 n = 28
Mean sd Mean sd Mean sd
Age (years) 40.4 (9.0) 46.8 (6.6) 38.6 (10.8)
Duration of employment (years) 17.4 (11.5) 26.3 (7.8) 18.8 (12.6)
BMI (kg/m2) 29.1 (3.7) 28.0 (1.7) 26.5 (2.6)
Glucose (mg/dL) 89.2 (12.4) 98.4 (11.0) 85.0 (12.1)
Urea (mg/dL) 36.0 (8.8) 40.6 (10.3) 31.1 (6.7)
Creatinine 1.0 (0.1) 0.9 (0.1) 0.9 (0.1)
Uric acid (mg/dL) 5.5 (1.3) 5.0 (0.2) 5.4 (0.9)
Liver function indicators
ALT (GPT) (U/L) 36.3 (18.4) 29.6 (12.1) 29.3 (13.2)
AST (GOT) (U/L) 22.7 (7.7) 18.4 (3.1) 21.0 (6.1)
GGT (U/L) 31.4 (15.5) 24.6 (6.4) 25.7 (17.4)
Lipid metabolism
Cholesterol (mg/dL) 216.7 (43.8) 200 (35.3) 207.2 (35.8)
LDL (mg/dL) 138.4 (44.4) 131.2 (29.6) 134.7 (31.8)
HDL (mg/dL) 47.7 (8.5) 44.2 (4.6) 46.2 (7.9)
Triglycerides (mg/dL) 143.0 (122.7) 122.6 (53.7) 133.3 (54.1)
Hematology
Hematocrit (%) 45.0 (2.6) 45.6 (3.3) 45.4 (2.7)
ESR (mm) 6.8 (5.6) 7.80 (7.1) 3.6 (2.0)
Leukocytes (WBC) (103) 7.51 (2.08) 7.57 (0.55) 8.10 (1.99)
Neutocytes (103) 4.23 (1.64) 4.29 (0.26) 4.62 (1.40)
Lymphocytes (103) 2.63 (0.77) 2.67 (0.25) 2.77 (0.51)
Monocytes (103) 0.43 (0.19) 0.40 (0.07) 0.44 (0.13)
Cr blood (μg/L) 1.14 (1.16) 0.26 (0.13) 0.64 (0.68)
Cr urine (μg/L) 1.84 (7.25) 0.20 (0.14) 0.68 (0.92)
Cr urine (μg/g creatinine) 1.20 (4.08) 0.09 (0.04) 0.45 (0.98)
Clusterin/ApoJ (OD492) 1165.1 (338.1) 1140.9 (178.4) 1176.3 (274.9)
BMI = body mass index; ALT (GPT) = alanine aminotrasferase; AST (GOT) = aspartate aminotransferase; GGT = γ-glutamyltranspeptidase; LDL = low-
density lipoprotein; HDL = high-density lipoprotein; ESR = erythrocyte sedimentation rate.
Table 2: Chromium blood and urine levels of welders entered worksite intervention (n = 9).
Welder Age Smoking status1
Cr blood (μg/L) Cr urine (μg/g creatinine) Cr urine (μg/L)
Intervention Intervention Intervention
pre post pre post pre post
1st 58 N 6.1 4.0 27.27 24.27 50.20 5.20
2nd 46 H 2.0 1.2 0.72 4.04 0.80 3.90
3rd 38 N 5.0 0.6 0.64 0.95 1.50 0.50
4th 40 M 2.9 0.3 1.03 0.43 1.10 0.20
5th 36 M 3.7 0.2 0.31 0.09 0.90 0.10
6th 37 L 2.5 2.7 0.65 2.40 1.20 1.60
7th 42 M 2.1 1.9 1.13 1.83 1.20 2.20
8th 35 L 3.0 1.6 1.94 2.64 3.10 3.20
9th 35 M 2.7 1.2 0.20 4.98 0.30 3.20
All mean 40.78 3.33 1.522 3.77 4.62 6.70 2.23
(SD) (7.40) (1.38) (1.22) (8.83) (7.54) (16.33) (1.79)
1N: nonsmokers; L: light (1–15 pack years); M: medium (16–30 pack years); H: heavy (>30 pack years)
2P<. 05, Wilcoxon signed ranks test.Evangelos C. Alexopoulos et al. 5
Table 3: Linear regression results modeling for ApoJ/CLU serum levels.
Variable Units of ββ coeﬃcient (95% CI) P value Model r2
MODEL 1 0.656
Cr blood μg/L 265.57 (71.38 to 1233.93) .015
Cr urine μg/g creatinine − 32.53 (− 70.04 to − 7.02) .024
MODEL 2 0.590
pre/post intervention ΔCr blood μg/L − 122.69 (− 213.69 to − 31.69) .015
these diseases represent states of increased oxidative stress
[29, 30]. By combining these ﬁndings, we proposed recently
that ApoJ/CLU upregulation during ageing or at age-related
diseases does not correlate to chronological age, but it rather
relates to increased oxidative damage which can be “sensed”
by the regulatory elements of the CLU gene promoter [28].
Although chronic exposure may induce secondary
molecularchanges,whichextendbeyondtheeﬀectsofoxida-
tive stress (e.g., inﬂammation or initiation of tumor forma-
tion) [22], our current ﬁndings strengthen further the no-
tion that the ApoJ/CLU is a sensitive biomarker of the or-
ganismal oxidative stress. More speciﬁcally, we report that
the CLU serum levels correlate positively to the workers ex-
posure to heavy metals and to Cr blood and urine concen-
tration. Cr in blood has been shown to reﬂect occupational
exposure to hexavalent chromium in stainless steel welding
[31] which gives support to the argument that the signiﬁ-
cant reduction of Cr levels after the intervention is mainly
due to the reduction of hexavalent chromium which is in
turnassumedtobetheresponsibleagentfortherelationwith
ApoJ/CLU found in our study. However, it should be consid-
ered that regarding the exposure to other metals there might
be some uncertainty in the assessment of the related biologi-
cal eﬀect. Lack of detailed knowledge of the kinetics of Cr in
the blood and in the elimination compartments, especially
urine, makes diﬃcult to evaluate the correct time and site for
sampling and the number of samples that should be taken.
It is suggested that a longitudinal study in occupationally
exposed participants besides Cr and ApoJ/CLU should also
include the measurement of the levels of well-known mark-
ers of oxidative damage such as the products of lipid perox-
idation [malondialdehyde(MDA)], DNA damage (modiﬁed
bases such as 8-oxo-dG), and/or protein carbonylation in or-
der to add ﬁrm basis to the proposed Cr-mediated oxidative
stress in the cells of occupational groups with similar expo-
sures as other studies have shown with various markers [32–
37].
In any case, this preliminary study gives evidence that the
human ApoJ/CLU gene is responsive to the acute oxidative
stress induced by heavy metals as hexavalent chromium, and
this ﬁnding may prove valuable during the monitoring and
re-evaluation of the long-term workers health eﬀects in cer-
tain occupational environments.
Abbreviations
Apolipoprotein J/Clusterin: ApoJ/CLU, (hexavalent)
chromium: Cr(VI).
ACKNOWLEDGMENT
The authors wish to thank all welders, sandblasters, and their
foremen for their participation, and Mr Ioakim Kantartzis,
Dipl. MEng., for his valuable technical advice.
REFERENCES
[1] E. C. Alexopoulos, “[Chemical hazards] in [Health eﬀects
of welding], ELINYAE Ed.,” 19–25, (in Greek), Athens,
Greece, 2007, http://www.elinyae.gr/el/item details.jsp?cat id
=33&item id=7126.
[2] K. S. Kasprzak, “The role of oxidative damage in metal car-
cinogenicity,”ChemicalResearchinToxicology,vol.4,no.6,pp.
604–615, 1991.
[ 3 ]K .B .B e c k m a na n dB .N .A m e s ,“ T h ef r e er a d i c a lt h e o r yo f
aging matures,” Physiological Reviews, vol. 78, no. 2, pp. 547–
581, 1998.
[4] A. Hartwig, “Recent advances in metal carcinogenicity,” Pure
and Applied Chemistry, vol. 72, no. 6, pp. 1007–1014, 2000.
[5] S. J. Stohs and D. Bagchi, “Oxidative mechanisms in the toxi-
city of metal ions,” Free Radical Biology and Medicine, vol. 18,
no. 2, pp. 321–336, 1995.
[6] J. M. Antonini, S. S. Leonard, J. R. Roberts, et al., “Eﬀect of
stainless steel manual metal arc welding fume on free radical
production, DNA damage, and apoptosis induction,” Molec-
ular and Cellular Biochemistry, vol. 279, no. 1-2, pp. 17–23,
2005.
[7] E. J. O’Flaherty, B. D. Kerger, S. M. Hays, and D. J. Pausten-
bach, “A physiologically based model for the ingestion of
chromium(III) and chromium(VI) by humans,” Toxicological
Sciences, vol. 60, no. 2, pp. 196–213, 2001.
[8] J. Alexander and J. Aaseth, “Uptake of chromate in human red
blood cells and isolated rat liver cells: the role of the anion car-
rier,” The Analyst, vol. 120, no. 3, pp. 931–933, 1995.
[ 9 ]A .K o r t e n k a m p ,D .B e y e r s m a n n ,a n dP .O ’ B r i e n ,“ U p t a k eo f
Cr(III) complexes by erythrocytes,” Toxicological and Environ-
mental Chemistry, vol. 14, pp. 23–32, 1987.
[10] M. D. Cohen, B. Kargacin, C. B. Klein, and M. Costa, “Mecha-
nisms of chromium carcinogenicity and toxicity,” Critical Re-
views in Toxicology, vol. 23, no. 3, pp. 255–281, 1993.
[11] A. Levina, R. Codd, C. T. Dillon, and P. A. Lay, “Chromium
in biology: toxicology and nutritional aspects,” in Progress in
Inorganic Chemistry, vol. 51, pp. 145–250, John Wiley & Sons,
New York, NY, USA, 2002.
[12] K. D. Sugden and D. M. Stearns, “The role of chromium(V)
in the mechanism of chromate-induced oxidative DNA dam-
ageandcancer,”JournalofEnvironmentalPathology,Toxicology
and Oncology, vol. 19, no. 3, pp. 215–230, 2000.
[13] A. Levina and P. A. Lay, “Mechanistic studies of relevance to
thebiologicalactivitiesofchromium,”CoordinationChemistry
Reviews, vol. 249, no. 3-4, pp. 281–298, 2005.6 Bioinorganic Chemistry and Applications
[14] A. Barchowsky and K. A. O’Hara, “Metal-induced cell signal-
ing and gene activation in lung diseases,” Free Radical Biology
and Medicine, vol. 34, no. 9, pp. 1130–1135, 2003.
[15] S. De Flora and K. E. Wetterhahn, “Mechanisms of chromium
metabolism and genotoxicity,” Life Chemistry Reports, vol. 7,
no. 3, pp. 169–244, 1989.
[16] A. M. Standeven and K. E. Wetterhahn, “ls there a role for re-
active oxygen species in the mechanism of chromium(VI) car-
cinogenesis?”ChemicalResearchinToxicology,vol.4,no.6,pp.
616–625, 1991.
[17] H. Salem and S. A. Katz, “Speciation, bioavailability, and sys-
temic distribution of chromium from Whetlerite dust,” The
Science of the Total Environment, vol. 86, no. 1-2, pp. 59–64,
1989.
[18] T.H.Lim,T.SargentIII,andN.Kusubov,“Kineticsoftraceel-
ementchromium(III)inthehumanbody,”TheAmericanJour-
nal of Physiology, vol. 244, no. 4, pp. R445–R454, 1983.
[19] P. C. Bragt and E. A. van Dura, “Toxicokinetics of hexava-
lent chromium in the rat after intratracheal administration of
chromatesofdiﬀerentsolubilities,”TheAnnalsofOccupational
Hygiene, vol. 27, no. 3, pp. 315–322, 1983.
[20] S. Yamaguchi, K. Sano, and N. Shimojo, “On the biological
half-time of hexavalent chromium in rats,” Industrial Health,
vol. 21, no. 1, pp. 25–34, 1983.
[21] K. H. Schaller, G. Csanady, J. Filser, B. J¨ ungert, and H. Drexler,
“Elimination kinetics of metals after an accidental exposure
to welding fumes,” International Archives of Occupational and
Environmental Health, vol. 80, no. 7, pp. 635–641, 2007.
[22] M. Katsiki, I. P. Trougakos, N. Chondrogianni, E. C. Alex-
opoulos, V. Makropoulos, and E. S. Gonos, “Alterations of
senescence biomarkers in human cells by exposure to CrVI in
vivoandinvitro,”Experimental Gerontology,v o l .3 9 ,n o .7 ,p p .
1079–1087, 2004.
[23] I. P. Trougakos and E. S. Gonos, “Clusterin/Apolipoprotein J
in human aging and cancer,” The International Journal of Bio-
chemistry & Cell Biology, vol. 34, no. 11, pp. 1430–1448, 2002.
[ 2 4 ] S .P o o n ,S .B .E a s t e r b r o o k - S m i t h ,M .S .R y b c h y n ,J .A .C a r v e r ,
and M. R. Wilson, “Clusterin is an ATP-independent chaper-
onewithverybroadsubstratespeciﬁcitythatstabilizesstressed
proteins in a folding-competent state,” Biochemistry, vol. 39,
no. 51, pp. 15953–15960, 2000.
[25] J. Angerer and K. H. Schaller, Analysis of Hazardous Substances
inBiologicalMaterials,Wiley-VCH,NewYork,NY,USA,1999.
[26] I. C. Stridsklev, K. H. Schaller, and S. Lang˚ ard, “Monitor-
ing of chromium and nickel in biological ﬂuids of stain-
less steel welders using the ﬂux-cored-wire (FCW) welding
method,” International Archives of Occupational and Environ-
mental Health, vol. 77, no. 8, pp. 587–591, 2004.
[27] M. Valko, H. Morris, and M. T. Cronin, “Metals, toxicity and
oxidative stress,” Current Medicinal Chemistry, vol. 12, no. 10,
pp. 1161–1208, 2005.
[28] I. P. Trougakos and E. S. Gonos, “Regulation of clus-
terin/apolipoprotein J, a functional homologue to the small
heat shock proteins, by oxidative stress in ageing and age-
related diseases,” Free Radical Research, vol. 40, no. 12, pp.
1324–1334, 2006.
[ 2 9 ]R .A .F l o y d ,M .S .W e s t ,K .L .E n e ﬀ, et al., “Conditions inﬂu-
encing yield and analysis of 8-hydroxy-2 -deoxyguanosine in
oxidatively damaged DNA,” Analytical Biochemistry, vol. 188,
no. 1, pp. 155–158, 1990.
[ 3 0 ]T .G r u n e ,T .J u n g ,K .M e r k e r ,a n dK .J .A .D a v i e s ,“ D e c r e a s e d
proteolysis caused by protein aggregates, inclusion bodies,
plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative
stress, aging, and disease,” The International Journal of Bio-
chemistry & Cell Biology, vol. 36, no. 12, pp. 2519–2530, 2004.
[31] J. L. Edm´ e, P. Shirali, M. Mereau, et al., “Assessment of biolog-
ical chromium among stainless steel and mild steel welders in
relation to welding processes,” International Archives of Occu-
pationalandEnvironmentalHealth,vol.70,no.4,pp.237–242,
1997.
[32] M. Travacio, J. M. Polo, and S. Llesuy, “Erratum to
“Chromium(VI)inducesoxidativestressinthemousebrain”,”
Toxicology, vol. 162, no. 2, pp. 139–148, 2001.
[33] N. J. Hodges, B. ´ Ad´ a m ,A .J .L e e ,H .J .C r o s s ,a n dJ .K .
Chipman, “Induction of DNA-strand breaks in human pe-
ripheral blood lymphocytes and A549 lung cells by sodium
dichromate: association with 8-oxo-2-deoxyguanosine forma-
tion and inter-individual variability,” Mutagenesis, vol. 16,
no. 6, pp. 467–474, 2001.
[ 3 4 ]Y . - D .K i m ,S . - C .A n ,T .O y a m a ,T .K a w a m o t o ,a n dH .K i m ,
“Oxidative stress, hogg1 expression and NF-κB activity in
cells exposed to low level chromium,” Journal of Occupational
Health, vol. 45, no. 5, pp. 271–277, 2003.
[35] A. J. Lee, N. J. Hodges, and J. K. Chipman, “Interindividual
variability in response to sodium dichromate-induced oxida-
tive DNA damage: role of the Ser
326Cys polymorphism in the
DNA-repair protein of 8-oxo-7,8-dihydro-2 -deoxyguanosine
DNA glycosylase 1,” Cancer Epidemiology Biomarkers & Pre-
vention, vol. 14, no. 2, pp. 497–505, 2005.
[36] M. Goulart, M. C. Bator´ e u ,A .S .R o d r i g u e s ,A .L a i r e s ,a n dJ .
Rueﬀ, “Lipoperoxidation products and thiol antioxidants in
chromium exposed workers,” Mutagenesis,v o l .2 0 ,n o .5 ,p p .
311–315, 2005.
[37] X.-F. Wang, M.-L. Xing, Y. Shen, X. Zhu, and L.-H. Xu, “Oral
administration of Cr(VI) induced oxidative stress, DNA dam-
age and apoptotic cell death in mice,” Toxicology, vol. 228,
no. 1, pp. 16–23, 2006.